Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 250-256

  Colao, Annamaria ^a   Pivonello, Rosario ^a   Cavallo, Luigi M ^a   Gaccione, Maria ^a   Auriemma, Renata S ^a   Esposito, Felice ^a   Cappabianca, Paolo ^a   Lombardi, Gaetano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ESTROGEN; GLUCOSE; OCTREOTIDE; SOMATOMEDIN; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGE; ARTICLE; CIRCADIAN RHYTHM; COMPARATIVE ANATOMY; DIAGNOSTIC ACCURACY; FEMALE; GROWTH HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REMISSION; STATISTICAL SIGNIFICANCE;

ACROMEGALY; ADULT; AGE FACTORS; AGED; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; POSTOPERATIVE PERIOD; PROLACTINOMA; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 33746067188     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02584.x     Document Type: Article

References (35)

1. Giustina, A., Barkan, A., Casanueva, F.F., Cavagnini, F., Frohman, L., Ho, K., Veldhuis, J., Wass, J., Von Werder, K. & Melmed, S. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology and Metabolism, 85, 526-529.
2. The Growth Hormone Research Society and The Pituitary Society (2004) Biochemical Assessment and Long-Term Monitoring in Patients with Acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 3099-3102.
3. Freda, P.U., Post, K.D., Powell, J.S. & Wardlaw, S.L. (1998) Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3808-3816.
4. Freda, P.U., Nuruzzaman, A.T., Reyes, C.M., Sundeen, R.E. & Post, K.D. (2004) Significance of 'abnormal' nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. Journal of Clinical Endocrinology and Metabolism, 89, 495-500.
5. Corpas, E., Harman, S.M. & Blackman, M.R. (1993) Human growth hormone and human aging. Endocrine Reviews, 14, 20-39.
6. Lamberts, S.W., van den Beld, A.W. & van der Lely, A.J. (1997) The endocrinology of aging. Science, 278, 419-424.
7. Ho, K.K. & Hoffman, D.M. (1993) Aging and growth hormone. Hormone Research, 40, 80-86.
8. van der Lely, A.J., Harris, A.G. & Lamberts, S.W. (1992) The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex. Clinical Endocrinology, 37, 181-185.
9. Turner, H.E., Adams, C.B.T. & Wass, J.A.H. (1999) Pituitary tumours in the elderly: a 20-year experience. European Journal of Endocrinology, 140, 383-389.
10. Freda, P.U., Landman, R.E., Sundeen, R.E. & Post, K.D. (2001) Gender and age in the biochemical assessment of cure of acromegaly. Pituitary, 4, 163-171.
11. Colao, A., Amato, G., Pedroncelli, A., Baldelli, R., Grottoli, S., Gasco, V., Petretta, M., Carella, C., Pagani, G., Tamburrano, G. & Lombardi, G. (2002) Gender- and age-related difference in the endocrine parameters of acromegaly. Journal of Endocrinological Investigation, 25, 532-538.
12. Colao, A., Ferone, D., Cappabianca, P., de Caro, M.L., Marzullo, P., Monticelli, A., Alfieri, A., Merola, B., Calì, A., de Divitiis, E. & Lombardi, G. (1997) Effect of octreotide pretreatment on surgical outcome in acromegaly. Journal of Clinical Endocrinology and Metabolism, 82, 3308-3314.
13. Colao, A., Ferone, D., Marzullo, P., Cappabianca, P., Cirillo, S., Boerlin, V., Lancranjan, I. & Lombardi, G. (2001) Long-term effects of depot long-acting somatostatin analogue octreotide on hormone levels and tumour mass in acromegaly. Journal of Clinical Endocrinology and Metabolism, 86, 2779-2786.
14. Stewart, P.M., Stewart, S.E., Clark, P.M. & Sheppard, M.C. (1999) Clinical and biochemical response following withdrawal of a long-acting, depot injection form of octreotide (Sandostatin-LAR). Clinical Endocrinology, 50, 295-299.
15. Frantz, A.G. & Rabkin, M.T. (1965) Effects of oestrogen and sex difference on secretion of human growth hormone. Journal of Clinical Endocrinology and Metabolism, 25, 1470-1480.
16. Burman, P., Johansson, A., Siegbahn, A., Vesby, B. & Karlsson, F.A. (1997) Growth (GH)-deficient men are more responsive to GH replacement therapy than women. Journal of Clinical Endocrinology and Metabolism, 82, 550-555.
17. Colao, A., Pivonello, R., Cappabianca, P., Briganti, F., Tortora, F., Auriemma, R.S., De Martino, M.C., Marzullo, P. & Lombardi, G. (2006) Effect of gender and gonadal status on the long-term response to somatostatin analogues treatment in acromegaly. Clinical Endocrinology, 63, 342-349.
18. World Health Organization. (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part. 1. Diagnosis and classification of diabetes mellitus. Geneva, World Health Organization.
19. Castelli, W.P. (1996) Lipid, risk factors and ischaemic heart disease. Atherosclerosis, 124, S1-S9.
20. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.E. & Turner, R.C. (1985) Homeostasis model assessment. Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
21. World Health Organization. (1996) Hypertension control. Report of a WHO Expert Committee. World Health Organization Technical Report Series, 862, 1-83.
22. Consensus Conference. (1984) Treatment of hypertriglyceridemia. Journal of the American Medical Association, 251, 1196-1200.
23. The Expert Panel. (1988) Report of the National Cholesterol Education Program expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Archives of Internal Medicine, 148, 36-39.
24. Freda, P.U. (2002) Somatostatin analogues in acromegaly. Journal of Clinical Endocrinology and Metabolism, 87, 3013-3018.
25. Clemmons, D.R., Van Wyk, J.J., Ridgway, E.C., Kliman, B., Kjellberg, R.N. & Underwood, L.E. (1979) Evaluation of acromegaly by radioimmunoassay of somatomedin-c. New England Journal of Medicine, 301, 1138-1142.
26. Swearingen, B., Barker, F.G., Katznelson, L., Biller, B.M., Grinspoon, S., Klibanski, A., Moayeri, N., Black, P.M. & Zervas, N.T. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419-3426.
27. Holdaway, I.M., Rajasoorya, R.C. & Gamble, G.D. (2004) Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 667-674.
28. Biermasz, N., Dekker, F.W., Pereira, A.M., van Thiel, S.W., Schutte, P.J., van Dulden, H., Romijn, J.A. & Roelfsema, F. (2004) Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements. Journal of Clinical Endocrinology and Metabolism, 89, 2789-2796.
29. Freda, P.U. (2003) Current concepts in the biochemical assessment of the patient with acromegaly. Growth Hormone and IGF Research, 13, 171-184.
30. Dobrashian, R.D., O'Halloran, D.J., Hunt, A., Beardwell, C.G. & Shalet, S.M. (1993) Relationships between insulin-like growth factor-I levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical Endocrinology, 38, 589-593.
31. Shalet, S.M. (2004) Biochemical monitoring of disease activity after surgery for acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 492-494.
32. Dimaraki, E.V., Jaffe, C.A., DeMott-Friberg, R., Chandler, W.F. & Barkan, A.L. (2002) Acromegaly with apparently normal GH secretion: implications for diagnosis and follow-up. Journal of Clinical Endocrinology and Metabolism, 87, 3537-3542.
33. Grortoli, S., Razzore, P., Gaia, D., Gasperi, M., Giusti, M., Colao, A., Ciccarelli, E., Gasco, V., Martino, E., Ghigo, E. & Camanni, F. (2003) Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly. Journal of Endocrinological Investigation, 26, 123-127.
34. Minuto, F., Resmini, E., Boschetti, M., Arvigo, M., Sormani, M.P., Giusti, M., Ferone, D. & Barreca, A. (2004) Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute post-glucose value with spontaneous GH secretion and with the IGF system. Clinical Endocrinology, 61, 138-144.
35. Parkinson, C., Renehan, A.G., Ryder, W.D., O'Dwyer, S.T., Shalet, S.M. & Trainer, P.J. (2002) Gender and age influence the relationship between serum GH and IGF-I in patients with acromegaly. Clinical Endocrinology, 57, 363-370.